CSL Annual Report 2024

Healthier World CSL continued to evolve its sustainability strategy and framework during the reporting period. In addition to executing on key environmental initiatives, CSL focused on expanding its focus areas, in previously termed ‘Social’ and ‘Workforce’ pillars, as well as setting preliminary targets that seek to enable healthier communities. CSL’s sustainability goals and targets position CSL to achieve its long‑term strategy in alignment with CSL’s purpose and values, creating a foundation for success and shared value creation through 2030 and beyond. HEALTHIER COMMUNITIES CSL understands that when it aligns its efforts with core expertise and business goals, addressing priority focus areas and material topics in the context of the business and the industry, it can have the greatest positive impact. CSL has evolved its sustainability strategy during the reporting period, with the goal of deploying its resources to service stakeholders in the focus areas of Access and Affordability, Patient Experience and Donor Experience. This is CSL’s commitment to ‘Healthier Communities’, because it recognises that healthier communities benefit all. CSL is committed to a healthier world. Our vision is a sustainable future for our employees, communities, patients and donors, inspired by innovative science and a values-driven culture and recognises that ‘Healthier Communities’ and a ‘Healthier Environment’ benefit all. In addition to material topics featured, CSL’s healthier communities focus areas include: • access & affordability – advance equitable access to our medicines and vaccines • patient experience – elevate patient experience in drug development by embedding patient insights and lived experience • donor experience – create best‑in‑class donor experience in partnership with donors and communities, by continuously innovating the donation process, supporting donors’ holistic well‑being, and investing in the health equity of donor communities. Limited Annual Report 2023/24 42

RkJQdWJsaXNoZXIy MjE2NDg3